The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Resolvedstocks

Health Canada Approves neffy as First Needle-Free Emergency Treatment for Anaphylaxis

First Detected: Apr 16, 2026, 5:01 AM

Last Update: 3 months ago

7 articles·6 stories

Event Summary

On April 16, Health Canada approved neffy as the first and only needle-free emergency treatment for anaphylaxis. This treatment is indicated for adults and children weighing 30 kg or more.

Timeline

Vanda Pharmaceuticals Launches Trial to Treat GLP-1 Side Effects

Apr 16, 2026, 10:02 PMImpact: 6

Aptar Digital Health and Enable Injections Partner for Digital Drug Delivery Solutions

Apr 16, 2026, 9:47 PMImpact: 4

Cosette Pharmaceuticals Acquires Assertio Holdings Portfolio for $48.9 Million

Apr 16, 2026, 9:33 PMImpact: 6

CLINUVEL Showcases Peptide and Vitiligo Treatments at AAD 2026

Apr 16, 2026, 9:01 AMImpact: 4

Alethio Therapeutics Unveils ATX-011 Antibody for Essential Thrombocythemia Market

Apr 16, 2026, 8:17 AMImpact: 6

Health Canada Approves neffy as First Needle-Free Emergency Treatment for Anaphylaxis

Apr 16, 2026, 5:01 AMImpact: 7

Health Canada Approves neffy as First Needle-Free Emergency Treatment for Anaphylaxis

Event Summary

Timeline

Price Impact